The chemokine receptor 5 Δ32 mutation is associated with increased renal survival in patients with IgA nephropathy
Ulf Panzer(Universität Hamburg), Rolf A.K. Stahl(Universität Hamburg), Detlef Schlöndorff(Suzuki (Japan)), Jan U. Becker(University Hospital Cologne), Ulrich Wenzel(Goethe University Frankfurt), Petra Barth(University of Tübingen), Tammo Ostendorf(RWTH Aachen University), Oliver M. Steinmetz(Universität Hamburg), Michael Fischereder(Ludwig-Maximilians-Universität München), U.D.O. Helmchen(University Medical Center Hamburg-Eppendorf), Andr Schneider(University Medical Center Hamburg-Eppendorf), Bernhard H. Kramer(University Medical Center Hamburg-Eppendorf), Sigrid Harendza(Universität Hamburg), Rdiger Reinking(University Medical Center Hamburg-Eppendorf), Gunther Zahner(Universität Hamburg)
Cited by 34
Related Papers
Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group
|Kidney International|2017|1.2k
Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus
|Circulation Research|2001|1.2k
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
|American Journal of Transplantation|2017|1k
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection
|American Journal of Transplantation|2020|809
The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology
|American Journal of Transplantation|2016|625